Concordance between Ki‑67 index in invasive breast cancer and molecular signatures: EndoPredict and MammaPrint-Reference-Cited by-同舟云学术

Concordance between Ki‑67 index in invasive breast cancer and molecular signatures: EndoPredict and MammaPrint

Published:2022-07-01 Issue:3 Volume:17 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Amezcua‑Gálvez Jesús¹,Lopez‑Garcia Carlos¹,Villarreal‑Garza Cynthia²,Lopez‑Rivera Victor³,Canavati‑Marcos Mauricio²,Santuario‑Facio Sandra⁴,Dono Antonio⁵,Monroig‑Bosque Paloma⁶,Ortiz‑López Rocío⁴,Leal‑Lopez Andrea²,Gómez‑macías Gabriela¹

Affiliation:

1. Department of Pathology, Tecnologico de Monterrey, Hospital San José, Av. Morones Prieto Poniente 3000 Poniente, Los Doctores, Monterrey, NL 64710, México

2. Breast Cancer Center, Tecnologico de Monterrey, Hospital Zambrano Hellion, Real San Agustín, San Pedro Garza García, NL 66278, México

3. Department of Neurology, UTHealth McGovern Medical School, The University of Texas Health Science Center at Houston, TX 77030, USA

4. School of Medicine and Health Sciences, Tecnologico de Monterrey, Av Morones Prieto, 3000 Poniente, Los Doctores, Monterrey, Nuevo León, 64710, México

5. Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, TX 77030, USA

6. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference45 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Molecular portraits of human breast tumours;Perou;Nature,2000

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci USA,2001

4. Personalizing the treatment of women with early breast cancer: Highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer 2013;Goldhirsch;Ann Oncol,2013

5. Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy;Gluck;Breast Cancer Res Treat,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis;Cancers;2024-06-26

2. The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment;Cancer Medicine;2023-05-28

3. The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations;Cancers;2023-01-28

4. Прогностическая и предиктивная значимость маркера Ki67 при раке молочной железы;Malignant tumours;2022-11-18